- Home
- INSM vs Z Comparison
INSM vs Z Comparison
Compare INSM & Z Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSM
- Z
- Stock Information
- Founded
- INSM 1988
- Z 2004
- Country
- INSM United States
- Z United States
- Employees
- INSM N/A
- Z N/A
- Industry
- INSM Biotechnology: Pharmaceutical Preparations
- Z Business Services
- Sector
- INSM Health Care
- Z Consumer Discretionary
- Exchange
- INSM Nasdaq
- Z Nasdaq
- Market Cap
- INSM 14.3B
- Z 17.0B
- IPO Year
- INSM 2000
- Z 2011
- Fundamental
- Price
- INSM $76.29
- Z $68.56
- Analyst Decision
- INSM Strong Buy
- Z Buy
- Analyst Count
- INSM 16
- Z 26
- Target Price
- INSM $95.36
- Z $81.64
- AVG Volume (30 Days)
- INSM 1.5M
- Z 2.8M
- Earning Date
- INSM 05-08-2025
- Z 04-30-2025
- Dividend Yield
- INSM N/A
- Z N/A
- EPS Growth
- INSM N/A
- Z N/A
- EPS
- INSM N/A
- Z N/A
- Revenue
- INSM $363,707,000.00
- Z $2,236,000,000.00
- Revenue This Year
- INSM $30.31
- Z $16.41
- Revenue Next Year
- INSM $118.39
- Z $14.79
- P/E Ratio
- INSM N/A
- Z N/A
- Revenue Growth
- INSM 19.17
- Z 14.96
- 52 Week Low
- INSM $21.92
- Z $38.45
- 52 Week High
- INSM $84.91
- Z $89.39
- Technical
- Relative Strength Index (RSI)
- INSM 46.23
- Z 37.89
- Support Level
- INSM $76.05
- Z $69.50
- Resistance Level
- INSM $79.12
- Z $74.49
- Average True Range (ATR)
- INSM 2.52
- Z 2.48
- MACD
- INSM -0.02
- Z 0.01
- Stochastic Oscillator
- INSM 38.63
- Z 29.11
About INSM Insmed Incorporated
Insmed Inc is a global biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. The company's earlier-stage clinical pipeline includes Brensocatib, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic potential in non-cystic fibrosis bronchiectasis and other inflammatory diseases; and INS1009, an inhaled formulation of a treprostinil prodrug that may offer a differentiated product profile for pulmonary arterial hypertension.
About Z Zillow Group Inc. Class C Capital Stock
Zillow Group Inc is an Internet-based real estate company that offers its customers an on-demand experience for selling, buying, renting, or financing with transparency and ease The group works with real estate agents, brokers, builders, property managers, and landlords to pair technology with top-notch service. The group has brands such as Zillow, Trulia, StreetEasy, Hotpads, Zillow Rentals, Zillow Home Loans, ShowingTime, Follow Up Boss, Aryeo and others.